annual total liabilities:
$948.74M+$470.35M(+98.32%)Summary
- As of today (June 22, 2025), ARWR annual total liabilities is $948.74 million, with the most recent change of +$470.35 million (+98.32%) on September 30, 2024.
- During the last 3 years, ARWR annual total liabilities has risen by +$647.41 million (+214.85%).
- ARWR annual total liabilities is now at all-time high.
Performance
ARWR Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$889.27M-$68.35M(-7.14%)Summary
- As of today (June 22, 2025), ARWR quarterly total liabilities is $889.27 million, with the most recent change of -$68.35 million (-7.14%) on March 31, 2025.
- Over the past year, ARWR quarterly total liabilities has increased by +$429.53 million (+93.43%).
- ARWR quarterly total liabilities is now -7.14% below its all-time high of $957.62 million, reached on December 31, 2024.
Performance
ARWR quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ARWR Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.3% | +93.4% |
| 3 y3 years | +214.8% | +253.9% |
| 5 y5 years | +796.6% | +1217.2% |
ARWR Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +246.8% | -7.1% | +253.9% |
| 5 y | 5-year | at high | +1462.3% | -7.1% | +1885.9% |
| alltime | all time | at high | >+9999.0% | -7.1% | >+9999.0% |
ARWR Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $889.27M(-7.1%) |
| Dec 2024 | - | $957.62M(+0.9%) |
| Sep 2024 | $948.74M(+98.3%) | $948.74M(+74.1%) |
| Jun 2024 | - | $544.78M(+18.5%) |
| Mar 2024 | - | $459.75M(+1.6%) |
| Dec 2023 | - | $452.57M(-5.4%) |
| Sep 2023 | $478.39M(+74.9%) | $478.39M(+15.6%) |
| Jun 2023 | - | $413.87M(-2.9%) |
| Mar 2023 | - | $426.20M(-13.9%) |
| Dec 2022 | - | $495.12M(+81.0%) |
| Sep 2022 | $273.60M(-9.2%) | $273.60M(-1.4%) |
| Jun 2022 | - | $277.61M(+10.5%) |
| Mar 2022 | - | $251.31M(-5.5%) |
| Dec 2021 | - | $265.98M(-11.7%) |
| Sep 2021 | $301.33M(+396.2%) | $301.33M(+1.1%) |
| Jun 2021 | - | $298.04M(-4.2%) |
| Mar 2021 | - | $311.25M(+595.1%) |
| Dec 2020 | - | $44.78M(-26.3%) |
| Sep 2020 | $60.73M(-42.6%) | $60.73M(-3.8%) |
| Jun 2020 | - | $63.14M(-6.5%) |
| Mar 2020 | - | $67.51M(-23.3%) |
| Dec 2019 | - | $88.07M(-16.8%) |
| Sep 2019 | $105.81M(+546.4%) | $105.81M(-4.8%) |
| Jun 2019 | - | $111.16M(-16.6%) |
| Mar 2019 | - | $133.30M(-21.3%) |
| Dec 2018 | - | $169.45M(+935.2%) |
| Sep 2018 | $16.37M(-29.3%) | $16.37M(+46.9%) |
| Jun 2018 | - | $11.14M(-16.1%) |
| Mar 2018 | - | $13.28M(-26.3%) |
| Dec 2017 | - | $18.02M(-22.2%) |
| Sep 2017 | $23.16M(-30.2%) | $23.16M(-9.3%) |
| Jun 2017 | - | $25.54M(-23.8%) |
| Mar 2017 | - | $33.54M(-28.7%) |
| Dec 2016 | - | $47.05M(+41.9%) |
| Sep 2016 | $33.15M(+46.4%) | $33.15M(+27.0%) |
| Jun 2016 | - | $26.11M(+26.2%) |
| Mar 2016 | - | $20.68M(+8.8%) |
| Dec 2015 | - | $19.01M(-16.0%) |
| Sep 2015 | $22.65M(+34.5%) | $22.65M(+56.8%) |
| Jun 2015 | - | $14.45M(-20.5%) |
| Mar 2015 | - | $18.18M(+10.7%) |
| Dec 2014 | - | $16.43M(-2.4%) |
| Sep 2014 | $16.83M(+45.2%) | $16.83M(+55.6%) |
| Jun 2014 | - | $10.82M(-17.5%) |
| Mar 2014 | - | $13.10M(+11.2%) |
| Dec 2013 | - | $11.78M(+1.6%) |
| Sep 2013 | $11.59M(+50.2%) | $11.59M(+41.7%) |
| Jun 2013 | - | $8.18M(-5.5%) |
| Mar 2013 | - | $8.66M(+13.5%) |
| Dec 2012 | - | $7.63M(-1.2%) |
| Sep 2012 | $7.72M | $7.72M(-4.0%) |
| Jun 2012 | - | $8.04M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $8.51M(+16.4%) |
| Dec 2011 | - | $7.31M(+120.0%) |
| Sep 2011 | $3.32M(-22.3%) | $3.32M(+22.2%) |
| Jun 2011 | - | $2.72M(-9.8%) |
| Mar 2011 | - | $3.01M(-61.8%) |
| Dec 2010 | - | $7.90M(+84.8%) |
| Sep 2010 | $4.28M(+50.3%) | $4.28M(-16.8%) |
| Jun 2010 | - | $5.14M(+125.5%) |
| Mar 2010 | - | $2.28M(-11.6%) |
| Dec 2009 | - | $2.58M(-9.3%) |
| Sep 2009 | $2.84M(-42.6%) | $2.84M(-36.6%) |
| Jun 2009 | - | $4.48M(-54.1%) |
| Mar 2009 | - | $9.76M(-6.0%) |
| Dec 2008 | - | $10.39M(+109.8%) |
| Sep 2008 | $4.95M(+45.8%) | $4.95M(+62.1%) |
| Jun 2008 | - | $3.06M(+9.4%) |
| Mar 2008 | - | $2.79M(+0.4%) |
| Dec 2007 | - | $2.78M(-18.0%) |
| Sep 2007 | $3.40M(+16.3%) | $3.40M(+15.5%) |
| Jun 2007 | - | $2.94M(+156.5%) |
| Mar 2007 | - | $1.15M(+12.9%) |
| Dec 2006 | - | $1.02M(-65.2%) |
| Sep 2006 | $2.92M(+185.1%) | $2.92M(+68.9%) |
| Jun 2006 | - | $1.73M(-33.2%) |
| Mar 2006 | - | $2.59M(+77.8%) |
| Dec 2005 | - | $1.46M(+42.2%) |
| Sep 2005 | $1.02M(+48.5%) | $1.02M(+3.2%) |
| Jun 2005 | - | $992.70K(+71.4%) |
| Mar 2005 | - | $579.20K(+64.6%) |
| Dec 2004 | - | $351.90K(-49.0%) |
| Sep 2004 | $689.70K(+616.9%) | $689.70K(+84.9%) |
| Jun 2004 | - | $373.00K(+871.4%) |
| Mar 2004 | - | $38.40K(+89.2%) |
| Dec 2003 | - | $20.30K(-78.9%) |
| Sep 2003 | $96.20K(-94.0%) | $96.20K(-94.7%) |
| Jun 2003 | - | $1.80M(+3.2%) |
| Mar 2003 | - | $1.74M(+6.1%) |
| Dec 2002 | - | $1.64M(+1.8%) |
| Sep 2002 | $1.61M(+19.5%) | $1.61M(+2.7%) |
| Jun 2002 | - | $1.57M(+10.0%) |
| Mar 2002 | - | $1.43M(+0.8%) |
| Dec 2001 | - | $1.42M(+4.8%) |
| Sep 2001 | $1.35M(+13.1%) | $1.35M(+3.8%) |
| Jun 2001 | - | $1.30M(+2.5%) |
| Mar 2001 | - | $1.27M(+3.9%) |
| Dec 2000 | - | $1.22M(+2.3%) |
| Sep 2000 | $1.19M(+10.7%) | $1.19M(-2.9%) |
| Jun 2000 | - | $1.23M(+4.7%) |
| Mar 2000 | - | $1.18M(+4.6%) |
| Dec 1999 | - | $1.12M |
| Sep 1999 | $1.08M(-62.6%) | - |
| Sep 1998 | $2.88M(+7.4%) | - |
| Sep 1997 | $2.68M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual total liabilities year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly total liabilities year-on-year change?
What is Arrowhead Pharmaceuticals annual total liabilities?
The current annual total liabilities of ARWR is $948.74M
What is the all time high annual total liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual total liabilities is $948.74M
What is Arrowhead Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ARWR annual total liabilities has changed by +$470.35M (+98.32%)
What is Arrowhead Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ARWR is $889.27M
What is the all time high quarterly total liabilities for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly total liabilities is $957.62M
What is Arrowhead Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ARWR quarterly total liabilities has changed by +$429.53M (+93.43%)